Skip to main contentAll experts

DrOlivier Pardo

Associate Professor in Cancer Cell Signalling

Department of Surgery & Cancer - Faculty of Medicine

Orcid identifier0000-0003-2223-1435 (opens in a new tab)⁠
  • Associate Professor in Cancer Cell Signalling
    Department of Surgery & Cancer - Faculty of Medicine
  • 020 7594 2814 (Work)
  • 0794 691 4196 (Mobile)
  • 145, ICTEM building, Hammersmith Campus, United Kingdom

PROFESSIONAL ACTIVITIES

  • RESEARCH STUDENT SUPERVISION
    SELECTED
    Selected
    PhD project-siRNA screening for modulators of lung cancer cells motility and invasiveness
    Lara R
  • RESEARCH STUDENT SUPERVISION
    SELECTED
    Selected
    PhD project: Drugable genome-wide study of lung cancer cell local invasion towards the endothelium
    Munro C
  • RESEARCH STUDENT SUPERVISION
    SELECTED
    Selected
    PhD project: Screening & Identification of Kinases Involved in Drug Resistance in Bladder Cancer
    Mufti U
  • RESEARCH STUDENT SUPERVISION
    SELECTED
    Selected
    PhD project: Targeting SRC family kinases in lung cancer
    Rupniewska E
  • GUEST LECTURE
    DrugSynthMC2.0: A Nested Monte Carlo Tree Search for the design of target-specific small molecules
    1 Jan 2025
    BioJapan 2025 - invited as part of the UK delegation
  • GUEST LECTURE
    hnRNPA1 in the regulation of osteosarcoma cells to immune cytokines
    1 Jan 2025
    Splicing 2025
  • GUEST LECTURE
    RSK4 and the regulation of drug resistance and metastasis in lung and bladder cancers
    1 Jan 2025
    BioST 2025 conference
  • COLLABORATION
    UNICAMP
    1 Jan 2025
  • COLLABORATION
    Brunel University
    1 Jan 2024
  • GUEST LECTURE
    hnRNPA1 in the regulation of osteosarcoma to immune cytokines
    1 Jan 2024
    Pediatric Cancer Research and Precision Medicine
  • GUEST LECTURE
    Identifying a Proteomics signature for Metothrexate-resistant GTD
    1 Jan 2024
    XXII World Congress on Gestational Trophoblastic Disease 2024
  • GUEST LECTURE
    S6 kinases and hnRNPA1 in osteosarcoma drug resistance and response to immune cytokines
    1 Jan 2024
    University of Southampton
  • GUEST LECTURE
    Targeting S6 kinases in Cancer
    1 Jan 2024
    Strenuous World Congress on Cancer science and Researcher Forum
  • GUEST LECTURE
    Targeting S6 kinases in Cancer - Keynote speaker
    1 Jan 2024
    CSMBFORUM2024
  • GUEST LECTURE
    RSK4 in the regulation of drug resistance and metastasis in lung and bladder cancers
    1 Jan 2023
    University of Southampton
  • GUEST LECTURE
    RSK4 in the regulation of drug resistance and metastasis in lung and bladder cancers
    1 Jan 2023
    SWCR 2023
  • GUEST LECTURE
    Targeting the crosstalk between mesothelioma cells and cancer-associated fibroblasts
    1 Jan 2023
    BACR Tumour Microenvironment Meeting
  • GUEST LECTURE
    Cancer Research 2022 - Keynote speaker
    1 Jan 2022
  • GUEST LECTURE
    European Society of Medicine General Assembly
    1 Jan 2022
  • GUEST LECTURE
    S6 kinases in Cancer
    1 Jan 2022
    University of Sussex
  • GUEST LECTURE
    Targeting ATR and CDK4/6 in therapy resistant GTD
    1 Jan 2022
    XXI World Congress on Gestational Trophoblastic Diseases
  • GUEST LECTURE
    Winter SWCR 2022, Singapore – Keynote speaker
    1 Jan 2022
  • GUEST LECTURE
    Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer
    1 Jan 2021
    European Association for Cancer Research 2021 annual conference
  • COLLABORATION
    Crick Institute
    1 Jan 2020
  • GUEST LECTURE
    hnRNPA1 phosphorylation and nucleocytoplasmic shuttling regulates IRES-driven mRNA translation
    1 Jan 2020
    SPLICING 2020, 3rd International Caparica Conference in Splicing